Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026441144> ?p ?o ?g. }
- W2026441144 endingPage "364" @default.
- W2026441144 startingPage "353" @default.
- W2026441144 abstract "Six 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (the present cholesterol-lowering drugs known as statins), lovastatin (L), simvastatin (S), pravastatin (P), fluvastatin (F), atorvastatin (A) and cerivastatin (C) are shown to be potent inhibitors of cholesterol synthesis in human hepatocytes, the target tissue for these drugs in man. All six inhibited in the nM range (IC(50) values: 0.2-8.0 nM). As daily used cholesterol-lowering drugs they are likely coadministered with other drugs. While several cytochrome P450 (CYP) enzymes are involved in drug metabolism in the liver and thus play an important role in drug-drug interaction it was investigated which of these enzymes are influenced by the active forms of the six statins. These enzyme activities were studied in human liver microsomal preparations, and in simian and human hepatocytes in primary culture. The following CYP reactions were used: nifedipine aromatization (CYP3A4), testosterone 6beta-hydroxylation (CYP3A4), tolbutamide methylhydroxylation (CYP2C9), S-mephenytoin 4-hydroxylation (CYP2C19), bufuralol 1'-hydroxylation (CYP2D6), aniline 4-hydroxylation (CYP2E1), coumarin 7-hydroxylation (CYP2A6) and 7-ethoxyresorufin O-dealkylation (CYP1A1/2). In the human liver microsomes the statins (concentrations up to 400 microM) did not influence the CYP1A1/2 activity and hardly the CYP2A6 and CYP2E1 activities. Except P, the other five statins were stronger inhibitors of the CYP2C19 activity with IC(50) values around 200 microM and the same holds for the effect of A, C and F on the CYP2D6 activity. L and S were weaker inhibitors of the latter enzyme activity, whereas P did not influence both activities. About the same was observed for the statin effect on CYP2C9 activity, except that F was a strong inhibitor of this activity (IC(50) value: 4 microM). Using the assay of testosterone 6beta-hydroxylation the CYP3A4 activity was decreased by L, S and F with IC(50) values of about 200 microM and a little more by C and A (IC(50) around 100 microM). P had hardly an effect on this activity. To a somewhat less extent the same trend was seen when CYP3A4 activity was measured using nifedipine as substrate. The inhibitory effects observed in microsomes were verified in suspension culture of freshly isolated hepatocytes from Cynomolgus monkey (as a readily available model) and of human hepatocytes. In general the same trends were seen as in the human microsomes, except that in some cases the inhibition of the CYP activity was less, possibly by the induction of the particular CYP enzyme by incubation of the cells with a particular statin. F remained a strong inhibitor of CYP2C9 activity in human and monkey hepatocytes. A induced the CYP2C9 in monkey hepatocytes but was an inhibitor of the CYP2C9 in human hepatocytes. A, S, L and C were moderate inhibitors in both cellular systems of CYP3A4. P was not affecting any of the CYP activities in the three systems studied. It is concluded that different CYP enzymes interact with different statins and therefore differences in between these drugs are to be expected when drug-drug interaction is considered." @default.
- W2026441144 created "2016-06-24" @default.
- W2026441144 creator A5000939657 @default.
- W2026441144 creator A5011594748 @default.
- W2026441144 creator A5028291081 @default.
- W2026441144 creator A5041185165 @default.
- W2026441144 creator A5077237302 @default.
- W2026441144 date "2000-12-01" @default.
- W2026441144 modified "2023-09-27" @default.
- W2026441144 title "Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes" @default.
- W2026441144 cites W1484689544 @default.
- W2026441144 cites W1520965071 @default.
- W2026441144 cites W158929996 @default.
- W2026441144 cites W1819324606 @default.
- W2026441144 cites W1941199801 @default.
- W2026441144 cites W1963829759 @default.
- W2026441144 cites W1969132469 @default.
- W2026441144 cites W1969215912 @default.
- W2026441144 cites W1972718956 @default.
- W2026441144 cites W1973002810 @default.
- W2026441144 cites W1991684478 @default.
- W2026441144 cites W2005169645 @default.
- W2026441144 cites W2014396691 @default.
- W2026441144 cites W2015318827 @default.
- W2026441144 cites W2025223069 @default.
- W2026441144 cites W2031561405 @default.
- W2026441144 cites W2033582596 @default.
- W2026441144 cites W2035975170 @default.
- W2026441144 cites W2067061069 @default.
- W2026441144 cites W2068150904 @default.
- W2026441144 cites W2074022399 @default.
- W2026441144 cites W2077207045 @default.
- W2026441144 cites W2077732105 @default.
- W2026441144 cites W2081088304 @default.
- W2026441144 cites W2083081513 @default.
- W2026441144 cites W2087015670 @default.
- W2026441144 cites W2090149382 @default.
- W2026441144 cites W2097471999 @default.
- W2026441144 cites W2098367156 @default.
- W2026441144 cites W2100458911 @default.
- W2026441144 cites W2111103048 @default.
- W2026441144 cites W2117164965 @default.
- W2026441144 cites W2125149319 @default.
- W2026441144 cites W2126543805 @default.
- W2026441144 cites W2145512527 @default.
- W2026441144 cites W2285363518 @default.
- W2026441144 doi "https://doi.org/10.1002/bdd.249" @default.
- W2026441144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11523064" @default.
- W2026441144 hasPublicationYear "2000" @default.
- W2026441144 type Work @default.
- W2026441144 sameAs 2026441144 @default.
- W2026441144 citedByCount "51" @default.
- W2026441144 countsByYear W20264411442012 @default.
- W2026441144 countsByYear W20264411442013 @default.
- W2026441144 countsByYear W20264411442014 @default.
- W2026441144 countsByYear W20264411442015 @default.
- W2026441144 countsByYear W20264411442016 @default.
- W2026441144 countsByYear W20264411442017 @default.
- W2026441144 countsByYear W20264411442018 @default.
- W2026441144 countsByYear W20264411442021 @default.
- W2026441144 countsByYear W20264411442023 @default.
- W2026441144 crossrefType "journal-article" @default.
- W2026441144 hasAuthorship W2026441144A5000939657 @default.
- W2026441144 hasAuthorship W2026441144A5011594748 @default.
- W2026441144 hasAuthorship W2026441144A5028291081 @default.
- W2026441144 hasAuthorship W2026441144A5041185165 @default.
- W2026441144 hasAuthorship W2026441144A5077237302 @default.
- W2026441144 hasConcept C109650736 @default.
- W2026441144 hasConcept C134018914 @default.
- W2026441144 hasConcept C134651460 @default.
- W2026441144 hasConcept C181199279 @default.
- W2026441144 hasConcept C185592680 @default.
- W2026441144 hasConcept C196013638 @default.
- W2026441144 hasConcept C2776054734 @default.
- W2026441144 hasConcept C2776329913 @default.
- W2026441144 hasConcept C2778163477 @default.
- W2026441144 hasConcept C2778417548 @default.
- W2026441144 hasConcept C2780940807 @default.
- W2026441144 hasConcept C2781109383 @default.
- W2026441144 hasConcept C526171541 @default.
- W2026441144 hasConcept C55493867 @default.
- W2026441144 hasConcept C555293320 @default.
- W2026441144 hasConcept C86745063 @default.
- W2026441144 hasConcept C86803240 @default.
- W2026441144 hasConcept C87644729 @default.
- W2026441144 hasConcept C98274493 @default.
- W2026441144 hasConceptScore W2026441144C109650736 @default.
- W2026441144 hasConceptScore W2026441144C134018914 @default.
- W2026441144 hasConceptScore W2026441144C134651460 @default.
- W2026441144 hasConceptScore W2026441144C181199279 @default.
- W2026441144 hasConceptScore W2026441144C185592680 @default.
- W2026441144 hasConceptScore W2026441144C196013638 @default.
- W2026441144 hasConceptScore W2026441144C2776054734 @default.
- W2026441144 hasConceptScore W2026441144C2776329913 @default.
- W2026441144 hasConceptScore W2026441144C2778163477 @default.
- W2026441144 hasConceptScore W2026441144C2778417548 @default.
- W2026441144 hasConceptScore W2026441144C2780940807 @default.
- W2026441144 hasConceptScore W2026441144C2781109383 @default.